- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
April 23rd, 2007
The Council for Scientific and Industrial Research (CSIR), in collaboration with international partner Ayanda Biosystems based at the Science Park of the Swiss Federal Institute of Technology in Lausanne is currently developing nanotechnology capsules for tuberculosis (TB) treatment.
Known as 'the technology of the very small', nanotechnology enables scientists to manipulate materials and particles that are a billionth of a metre, or about 1/80 000th of the diameter of a human hair.
The nanocapsules were being tested on animals, and the developers hoped that they would eventually decrease the number and frequency of drugs used by TB patients.
|Related News Press|
Nanoscale Trojan horses treat inflammation May 24th, 2016
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers
Doubling down on Schrödinger's cat May 27th, 2016
Are humans the new supercomputer?Today, people of all backgrounds can contribute to solving serious scientific problems by playing computer games. A Danish research group has extended the limits of quantum physics calculations and simultaneously blurred the boundaries between mac April 14th, 2016
UCLA nanoscientists engage shoppers in fun conversations March 8th, 2016
Risk Analysis Publishes Non-Animal Strategy to Assess Nanomaterials February 24th, 2016